Category

Latest News
The World Health Organization (WHO) is advising Member States that are leading the response to the unfolding COVID-19 pandemic. The WHO Global TB Programme, along with WHO regional and country offices, has developed an information note, in collaboration with stakeholders. This note is intended to assist national TB programmes and health personnel to urgently maintain...
Read More
Dear friends, colleagues and partners, As COVID-19 spreads across the globe, we hope that each and everyone one of you is keeping safe and taking all the measures you can to flatten the curve, including social distancing, washing hands, and other hygiene measures. This year for World TB Day, the IMPAACT4TB partners had planned a...
Read More
New, shorter treatment to prevent TB to be rolled out in five high-burden TB countries Three-month regimen expected to prevent TB in those at highest risk of developing the disease, including people living with HIV and children under the age of five 24 March 2020 (Johannesburg, South Africa) – Today, the Aurum Institute and its...
Read More
Unitaid, the Global Fund to Fight AIDS, Tuberculosis and Malaria, Sanofi SA, and the Stop TB Partnership is pleased to announce a significant reduction in the price of rifapentine (Priftin®) manufactured by Sanofi SA. Read more here
Read More
Press Release Pricing Agreement Makes TB Prevention Affordable for High-Burden, Low-, Lower-Middle and Upper-Middle Income Countries Aurum Institute on behalf of the IMPAACT4TB project congratulates Unitaid, the Global Fund to Fight AIDS, Tuberculosis and Malaria and Sanofi for having reached a volume-based agreement, securing a significant price discount for rifapentine (Priftin®) Hyderabad (31 October 2019)—A...
Read More
The IMPAACT4TB Consortium will be hosting a Satellite Session at the Union Conference as an introduction to a Short Course Prevention Therapy, 3HP. Looking forward to seeing you there!  
Read More
The latest WHO Global TB report  2019 was published on 20 October 2019 and has been every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in the prevention, diagnosis and treatment of the disease, at global, regional and country...
Read More
1 2